Munafa Stock Market Course + Intraday & FNO calls 
Urogen Pharma (URGN) Technical (Analysis) Reports Urogen Pharma ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Urogen Pharma (URGN)
Technical Analysis Report for NASDAQ stock URGN Urogen Pharma. Dated: 06 Feb 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock URGN Urogen Pharma then click here. or read Experts views on Urogen Pharma or Forecast & share price targets of Urogen Pharma
Urogen Pharma Opened at 20.68 and Closed at: 21.35, which is 3.89% of previous session's close. It moved within a range of 20.68 and 21.77
The session was a Bullish session with an average volume of 751100, which is -37% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
A Golden cross was found 3 days back on short term averages
Support for tomorrow is 21.02 and resistance for tomorrow is 22.11
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 20.76, 20.18 resistance for tomorrow's hourly charts is 21.85, 22.36
10 Day SMA for Urogen Pharma (URGN) is 20.68 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Urogen Pharma (URGN) is 20.25 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Urogen Pharma (URGN) is 22.36 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 21.09 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Urogen Pharma is 17.47 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Urogen Pharma is at 20.25 and 200 DMA is at 17.47, while 50 DMA and 100 DMA are at 22.36 and 21.09 respectively
Urogen Pharma (URGN) moving average of 20 SMA is at 20.25 and 20 EMA is at 20.75
| Date | Closing Price | 20 SMA | 20 EMA |
| 06 Fri Feb | 21.35 | 20.25 | 20.75 |
| 05 Thu Feb | 20.52 | 20.36 | 20.69 |
| 04 Wed Feb | 20.71 | 20.49 | 20.71 |
| 03 Tue Feb | 20.00 | 20.55 | 20.71 |
| 02 Mon Feb | 19.70 | 20.65 | 20.79 |
| 30 Fri Jan | 19.61 | 20.8 | 20.9 |
Urogen Pharma (URGN) moving average of 50 SMA is at 22.36 and 50 EMA is at 21.34
| Date | Closing Price | 50 SMA | 50 EMA |
| 06 Fri Feb | 21.35 | 22.36 | 21.34 |
| 05 Thu Feb | 20.52 | 22.47 | 21.34 |
| 04 Wed Feb | 20.71 | 22.58 | 21.37 |
| 03 Tue Feb | 20.00 | 22.66 | 21.4 |
| 02 Mon Feb | 19.70 | 22.77 | 21.46 |
| 30 Fri Jan | 19.61 | 22.84 | 21.53 |
Urogen Pharma (URGN) moving average of 100 SMA is at 21.09 and 100 EMA is at 20.71
| Date | Closing Price | 100 SMA | 100 EMA |
| 06 Fri Feb | 21.35 | 21.09 | 20.71 |
| 05 Thu Feb | 20.52 | 21.05 | 20.7 |
| 04 Wed Feb | 20.71 | 21.04 | 20.7 |
| 03 Tue Feb | 20.00 | 21.02 | 20.7 |
| 02 Mon Feb | 19.70 | 21.01 | 20.71 |
| 30 Fri Jan | 19.61 | 21.02 | 20.73 |
Urogen Pharma (URGN) moving average of 200 SMA is at 17.47 and 200 EMA is at 18.73
| Date | Closing Price | 200 SMA | 200 EMA |
| 06 Fri Feb | 21.35 | 17.47 | 18.73 |
| 05 Thu Feb | 20.52 | 17.41 | 18.7 |
| 04 Wed Feb | 20.71 | 17.36 | 18.68 |
| 03 Tue Feb | 20.00 | 17.31 | 18.66 |
| 02 Mon Feb | 19.70 | 17.26 | 18.65 |
| 30 Fri Jan | 19.61 | 17.21 | 18.64 |
Xtl Biopharmaceuticals has performed better than Urogen Pharma in short term. You could have earned much better returns by investing in Xtl Biopharmaceuticals, about 59.23% more returns!
Urogen Pharma has performed better than Verastem Inc in short term. Holding Urogen Pharma could be a better choice for now!
Theravance Biopharma has performed better than Urogen Pharma in short term. You could have earned much better returns by investing in Theravance Biopharma, about 7.09% more returns!
Urogen Pharma has performed better than Proqr Therapeutics in short term. Holding Urogen Pharma could be a better choice for now!
Phibro Animal has performed better than Urogen Pharma in short term. You could have earned much better returns by investing in Phibro Animal, about 34.09% more returns!
Intellia Therapeutics has performed better than Urogen Pharma in short term. You could have earned much better returns by investing in Intellia Therapeutics, about 17.74% more returns!
Minerva Neurosciences has performed better than Urogen Pharma in short term. You could have earned much better returns by investing in Minerva Neurosciences, about 7.4% more returns!
Urogen Pharma has performed better than Endra Life in short term. Holding Urogen Pharma could be a better choice for now!
Neurocrine Biosciences has performed better than Urogen Pharma in short term. You could have earned much better returns by investing in Neurocrine Biosciences, about 3.51% more returns!
Moleculin Biotech has performed better than Urogen Pharma in short term. You could have earned much better returns by investing in Moleculin Biotech, about 9.2% more returns!
Lipocine Inc has performed better than Urogen Pharma in short term. You could have earned much better returns by investing in Lipocine Inc, about 5.52% more returns!
Urogen Pharma has performed better than Lifevantage Corporation in short term. Holding Urogen Pharma could be a better choice for now!
Urogen Pharma has performed better than Arbutus Biopharma in short term. Holding Urogen Pharma could be a better choice for now!
Urogen Pharma has performed better than Ac Immune in short term. Holding Urogen Pharma could be a better choice for now!
Urogen Pharma has performed better than Autolus Therapeutics in short term. Holding Urogen Pharma could be a better choice for now!
Dynavax Technologies has performed better than Urogen Pharma in short term. You could have earned much better returns by investing in Dynavax Technologies, about 0.11% more returns!
Fate Therapeutics has performed better than Urogen Pharma in short term. You could have earned much better returns by investing in Fate Therapeutics, about 8.1% more returns!
Urogen Pharma has performed better than Hologic Inc in short term. Holding Urogen Pharma could be a better choice for now!
Urogen Pharma has performed better than Iterum Therapeutics in short term. Holding Urogen Pharma could be a better choice for now!
Urogen Pharma Technical analysis of indicators
Price action analysis of Urogen Pharma (URGN) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Urogen Pharma stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Urogen Pharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Urogen Pharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Urogen Pharma in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Urogen Pharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 20.69 and Urogen Pharma URGN stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Urogen Pharma URGN stock. Volume based technical analysis of Urogen Pharma URGN stock is negative.
Urogen Pharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock URGN Urogen Pharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And URGN Experts View which covers a lot of information including buying and selling signals
URGN future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Urogen Pharma or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Urogen Pharma (URGN) Technical (Analysis) Reports Urogen Pharma ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
